Skip to main content
Clinical Trials/NCT00379301
NCT00379301
Completed
Not Applicable

Efficacy of Different Ablation Strategies in Achieving Long-Term Arrhythmia Control in Patients With Persistent or Permanent Atrial Fibrillation

University of Pennsylvania1 site in 1 country166 target enrollmentOctober 2006

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Atrial Fibrillation
Sponsor
University of Pennsylvania
Enrollment
166
Locations
1
Primary Endpoint
Long-term (greater than 6 months) arrhythmia control in patients with persistent or permanent AF
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

This study involves treatment for atrial fibrillation (AF)-the most common heart condition in the US-where the upper chambers of the heart beat very fast and in a disorganized manner. This can be felt as palpitations, tiredness, shortness of breath and passing out, plus can lead to stroke, damage to the heart muscle and a shorter life span. Study participants will receive a common treatment for atrial fibrillation called radiofrequency ablation (RFA), where small lesions or "burns" are made inside the heart to cut off the abnormal impulses that cause AF. The purpose of this study is to compare the effectiveness of three different common ablation strategies in patients with persistent or permanent AF. Subjects will be randomized (like drawing straws) to be treated with one of the three strategies to see if there is a difference in how well atrial fibrillation is controlled after treatment.

Detailed Description

In most cases, AF originates where the pulmonary veins (PV) enter the left upper chamber of the heart, known as the left atrium (LA). Common to the procedure in each arm of the study is pulmonary vein isolation (PVI) or ablation of tissue around the pulmonary vein entrances. After PVI, the procedure continues with ablation in other areas of the LA where similar abnormal impulses are found. The three strategies for continuing with ablation after PVI are described in the "Arms" section below.

Registry
clinicaltrials.gov
Start Date
October 2006
End Date
October 2011
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All patients of age ≥ 30 years, undergoing their first ablation procedure that meet ACC / AHA defined criteria for persistent or permanent AF will be eligible to participate in the study. This includes patients with a history of AF episodes lasting at least 7 days or requiring at least 2 cardioversions.

Exclusion Criteria

  • Patients with paroxysmal AF (self-terminating episodes lasting \< 7 day)
  • Patients who have had a previous AF ablation procedure
  • Failure to obtain informed consent
  • Less than 30 years old

Outcomes

Primary Outcomes

Long-term (greater than 6 months) arrhythmia control in patients with persistent or permanent AF

Time Frame: 6 - 12 months

Study Sites (1)

Loading locations...

Similar Trials